Overview
John Phan is a primary care provider, practicing in Internal Medicine in San Jose, California. Dr. Phan is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Maturity Onset Diabetes of the Young, Familial Hypertension, Hypertension, and Glucocorticoid-Remediable Aldosteronism.
His clinical research consists of co-authoring 2 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- MEDICARE MAPD
- MEDICARE SNP
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- HMO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1991 Mckee Rd, San Jose, CA 95116
1993 Mckee Rd, San Jose, CA 95116
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Won Kim is a primary care provider, practicing in Internal Medicine in San Francisco, California. Dr. Kim is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are WT1-Related Wilms Tumor Syndromes, Chromophobe Renal Cell Carcinoma, Renal Cell Carcinoma (RCC), Angioplasty, and Percutaneous Coronary Intervention (PCI).
Yin-yin Myint is a primary care provider, practicing in Internal Medicine in South San Francisco, California. Dr. Myint is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. Her top areas of expertise are Type 2 Diabetes (T2D), Clear Cell Sarcoma, Renal Cell Carcinoma (RCC), and Chromophobe Renal Cell Carcinoma.
Ucsf Medical Group Business Services
Hala Borno is a primary care provider, practicing in Internal Medicine in Berkeley, California. Dr. Borno is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. Her top areas of expertise are Renal Cell Carcinoma (RCC), Clear Cell Sarcoma, Familial Wilms Tumor 2, WT1-Related Wilms Tumor Syndromes, and Orchiectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Familial HypertensionDr. Phan isAdvanced. Learn about Familial Hypertension.
- Glucocorticoid-Remediable Aldosteronism
- HepatitisDr. Phan isAdvanced. Learn about Hepatitis.
- HypertensionDr. Phan isAdvanced. Learn about Hypertension.
- JaundiceDr. Phan isAdvanced. Learn about Jaundice.
- Maturity Onset Diabetes of the Young
- Experienced
- Acute Eosinophilic PneumoniaDr. Phan isExperienced. Learn about Acute Eosinophilic Pneumonia.
- AnemiaDr. Phan isExperienced. Learn about Anemia.
- AsthmaDr. Phan isExperienced. Learn about Asthma.
- Asthma in ChildrenDr. Phan isExperienced. Learn about Asthma in Children.
- BronchitisDr. Phan isExperienced. Learn about Bronchitis.
- Chromophobe Renal Cell CarcinomaDr. Phan isExperienced. Learn about Chromophobe Renal Cell Carcinoma.